N-(4-cyanophenyl)-2-(4-(2,4-dioxo-1,3-dipropyl-2,3,4,5-tetrahydro-1H-pyrrolo[3,2-d]pyrimidin-6-yl)phenoxy)acetamide
N-(4-cyanophenyl)-2-(4-(2,4-dioxo-1,3-dipropyl-2,3,4,5-tetrahydro-1H-pyrrolo[3,2-d]pyrimidin-6-yl)phenoxy)acetamide
SMILES |
CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=C2)C3=CC=C(C=C3)OCC(=O)NC4=CC=C(C=C4)C#N |
InChIKey |
BECUPSZIIZFXCR-UHFFFAOYSA-N |
Chemical Properties
Hydrogen bond acceptors |
7 |
Hydrogen bond donors |
2 |
Rotatable bonds |
9 |
Molecular weight (Da) |
485.2 |
Bioactivities
|
Receptor |
Activity |
Source |
Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
Receptor |
Activity |
Source |
Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
N-(4-cyanophenyl)-2-(4-(2,4-dioxo-1,3-dipropyl-2,3,4,5-tetrahydro-1H-pyrrolo[3,2-d]pyrimidin-6-yl)phenoxy)acetamide
Drug properties
Molecular type |
Small molecule |
Physiological/Surrogate |
Surrogate |
Approved drug |
No |
Clinical Trials
Phase I
0
Phase II
0
Phase III
0
Approved
No
Sankey plot
Compound is not listed as a drug.